39
Participants
Start Date
September 30, 2008
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
Aliskiren
300 mg once daily
Placebo
Matching placebo once daily
Retinal Consultants of Arizona, Phoenix
Retina-Vitreous Associates, Los Angeles
National Ophthalmic Research Institute, Fort Myers
Georgia Retina, Atlanta
Elman Retina Group, Baltimore
Vitreo-Retinal Associates, Grand Rapids
Retina-Associates of Cleveland, Inc, Beachwood
Novartis Investigative Site, Aarhus
Novartis Investigative Site, Copenhagen
Joslin Clinic, Boston
Charlotte Eye, Ear, Nose and Throat Associate, Charlotte
Retinal Consultants of Houston, Houston
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY